MENU
ZBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Zenas Biopharma (ZBIO) Ownership - Who owns Zenas Biopharma?
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
863.68M
P/E Ratio
N/A
Total Cash
273.28M
Projected Growth
N/A
Total Debt
1.01M
Revenue
15M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.49
Total Debt/Equity
N/A
Revenue/Share
0.36 USD as % of share price
Fundamentals
ZBIO
Capitalization
864M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
273M
Total Cash/Share
6.49
Total Debt
1.01M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.36%
Revenue
15M
ROE
N/A
Book Value
240M
P/B Ratio
3.60
Cash Flow
N/A
Earnings
-12.29
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
5.23
Current Revenue Per Employee
76923.08
Dividends Per Share - Security
N/A
EBITDA
-189M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-71.80
Shares Held By Institutions
396M
Shares Outstanding - Current
42.1M
Total Liabilities
53.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
150.427
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information